Sign in

CIK 0001422142

  • Non-accelerated filer
  • Smaller reporting company

Whitehawk Therapeutics, Inc.

Sign in to watch
Ticker
WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547850
Phone
+1 551-321-2234
Business address
2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
Former names
Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Planned sale Executive Chairman sold 42,000 shares at $1.74 ($73,269)
  4. 4 Open-market sale Executive Chairman sold 42,000 shares at $2.06 ($86,549)
  5. 4 Open-market sale Executive Chairman sold 7,037 shares at $4.82 ($33,914)
  6. 4 Open-market sale Executive Chairman sold 34,963 shares at an average $5.09 ($177,808)
  7. 4 Open-market sale Executive Chairman sold 42,000 shares at an average $4.42 ($185,750)
  8. 4 Open-market sale Executive Chairman sold 42,000 shares at an average $4.26 ($179,001)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Executive Chairman sold 42,000 shares at an average $5.69 ($238,826)
  12. 4 Open-market sale Executive Chairman sold 42,000 shares at an average $5.21 ($218,774)
  13. 4 Open-market sale Executive Chairman sold 42,000 shares at an average $6.47 ($271,592)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Executive Chairman sold 7,260 shares at $8.19 ($59,453)

Page 5 of 14 · 263 filings